| Item Number | Description | Schedule Fee |
|---|---|---|
| 61564 | Whole body prostate-specific membrane antigen PET study performed for the restaging of recurrent prostate adenocarcinoma, for a patient who:(a) has undergone prior locoregional therapy; and(b) is considered suitable for further locoregional therapy to determine appropriate therapeutic pathways and timing of treatment initiation Applicable twice per lifetime (R) |
$1,300.00 |
| Total: | $1,300.00 | |